Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 11/20 | 0.43 |
| ▸ | HCRTR2 | O43614 | 11/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | IKBKB | O14920 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7042463 | 0.85 | CA12 (0.57) | ALDH1A1L3MBTL1HCRTR1HCRTR2HTT | |
| SCHEMBL24936303 | 0.84 | CA9 (0.42) | ALDH1A1L3MBTL1HCRTR1HCRTR2HTT | |
| SCHEMBL6671479 | 0.83 | HCRTR2 (0.47) | ALDH1A1HCRTR1HCRTR2CA12CA1 | |
| SCHEMBL1534624 | 0.83 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1HTTRAB9ACA12 | |
| SCHEMBL2527155 | 0.82 | KDM4E (0.42) | ALDH1A1L3MBTL1HCRTR1HCRTR2CA12 | |
| SCHEMBL31289996 | 0.82 | CA1 (0.55) | ALDH1A1L3MBTL1CA12CA1CA2 | |
| SCHEMBL31289933 | 0.82 | CA1 (0.55) | ALDH1A1L3MBTL1CA12CA1CA2 | |
| SCHEMBL14090941 | 0.82 | CA12 (0.46) | ALDH1A1L3MBTL1HCRTR1HCRTR2HTT | |
| SCHEMBL7040741 | 0.82 | IKBKB (0.50) | ALDH1A1L3MBTL1HTTRAB9ACA12 | |
| SCHEMBL31150976 | 0.82 | CA12 (0.41) | ALDH1A1L3MBTL1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103992290-A | Diarylethene structure similar compounds as well as preparation method and application thereof | INST MEDICINAL BIOTECHNOLOGY | 2014-08-20 | — | — | CN | disclosed |
| US-20040220403-A1 | 1-(2-Methoxybenzyl)-3-benzhydrylpiperazines as tachykinin anatgonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-11-04 | — | — | US | disclosed |
| EP-1368343-A1 | 1-(2-METHOXYBENZYL)-3-BENZHYDRYLPIPERAZINES AS TACHYKININ ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002055518-A1 | 1-(2-METHOXYBENZYL)-3-BENZHYDRYLPIPERAZINES AS TACHYKININ ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040220403-A1 | 1-(2-Methoxybenzyl)-3-benzhydrylpiperazines as tachykinin anatgonists | BDKRB1, BDKRB2, TACR1 | ALDH1A1 1825/4885L3MBTL1 2647/4885HCRTR1 138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.